324 related articles for article (PubMed ID: 28099825)
41. Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
Moodley P; Shah NS; Tayob N; Connolly C; Zetola N; Gandhi N; Friedland G; Sturm AW
PLoS One; 2011; 6(5):e17513. PubMed ID: 21655324
[TBL] [Abstract][Full Text] [Related]
42. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
[TBL] [Abstract][Full Text] [Related]
43. Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
Hu Y; Zhao Q; Werngren J; Hoffner S; Diwan VK; Xu B
BMC Infect Dis; 2016 Jan; 16():4. PubMed ID: 26739444
[TBL] [Abstract][Full Text] [Related]
44. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa.
Klopper M; Warren RM; Hayes C; Gey van Pittius NC; Streicher EM; Müller B; Sirgel FA; Chabula-Nxiweni M; Hoosain E; Coetzee G; David van Helden P; Victor TC; Trollip AP
Emerg Infect Dis; 2013 Mar; 19(3):449-55. PubMed ID: 23622714
[TBL] [Abstract][Full Text] [Related]
45. Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.
Naidoo CC; Pillay M
J Genet; 2017 Sep; 96(4):599-612. PubMed ID: 28947708
[TBL] [Abstract][Full Text] [Related]
46. Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.
Heysell SK; Thomas TA; Gandhi NR; Moll AP; Eksteen FJ; Coovadia Y; Roux L; Babaria P; Lalloo U; Friedland G; Shah S
BMC Infect Dis; 2010 Dec; 10():344. PubMed ID: 21134279
[TBL] [Abstract][Full Text] [Related]
47. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
Nkurunziza J; Karstaedt AS; Louw R; Padanilam X
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319
[TBL] [Abstract][Full Text] [Related]
48. Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South Africa.
Nelson KN; Jenness SM; Mathema B; Lopman BA; Auld SC; Shah NS; Brust JCM; Ismail N; Omar SV; Brown TS; Allana S; Campbell A; Moodley P; Mlisana K; Gandhi NR
Clin Infect Dis; 2020 May; 70(11):2396-2402. PubMed ID: 31342067
[TBL] [Abstract][Full Text] [Related]
49. The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study.
Cohen T; Murray M; Wallengren K; Alvarez GG; Samuel EY; Wilson D
PLoS Med; 2010 Jun; 7(6):e1000296. PubMed ID: 20582324
[TBL] [Abstract][Full Text] [Related]
50. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
Gandhi NR; Moll A; Sturm AW; Pawinski R; Govender T; Lalloo U; Zeller K; Andrews J; Friedland G
Lancet; 2006 Nov; 368(9547):1575-80. PubMed ID: 17084757
[TBL] [Abstract][Full Text] [Related]
51. Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
Wang XH; Ma AG; Han XX; Gu XM; Fu LP; Li PG; Li FY; Wang QZ; Liang H; Katar A; Wang LJ
Med Sci Monit; 2015 May; 21():1313-8. PubMed ID: 25950148
[TBL] [Abstract][Full Text] [Related]
52. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
53. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.
Pietersen E; Ignatius E; Streicher EM; Mastrapa B; Padanilam X; Pooran A; Badri M; Lesosky M; van Helden P; Sirgel FA; Warren R; Dheda K
Lancet; 2014 Apr; 383(9924):1230-9. PubMed ID: 24439237
[TBL] [Abstract][Full Text] [Related]
54. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
Naidoo CC; Pillay M
Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
[TBL] [Abstract][Full Text] [Related]
55. Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa.
Kapwata T; Morris N; Campbell A; Mthiyane T; Mpangase P; Nelson KN; Allana S; Brust JCM; Moodley P; Mlisana K; Gandhi NR; Shah NS
PLoS One; 2017; 12(10):e0181797. PubMed ID: 29028800
[TBL] [Abstract][Full Text] [Related]
56. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.
Pepper DJ; Rebe K; Morroni C; Wilkinson RJ; Meintjes G
PLoS One; 2009; 4(2):e4520. PubMed ID: 19229341
[TBL] [Abstract][Full Text] [Related]
57. Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.
Thomas TA; Shenoi SV; Heysell SK; Eksteen FJ; Sunkari VB; Gandhi NR; Friedland G; Shah NS
Int J Tuberc Lung Dis; 2010 Oct; 14(10):1244-51. PubMed ID: 20843414
[TBL] [Abstract][Full Text] [Related]
58. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.
Dheda K; Limberis JD; Pietersen E; Phelan J; Esmail A; Lesosky M; Fennelly KP; Te Riele J; Mastrapa B; Streicher EM; Dolby T; Abdallah AM; Ben-Rached F; Simpson J; Smith L; Gumbo T; van Helden P; Sirgel FA; McNerney R; Theron G; Pain A; Clark TG; Warren RM
Lancet Respir Med; 2017 Apr; 5(4):269-281. PubMed ID: 28109869
[TBL] [Abstract][Full Text] [Related]
59. Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa.
Shah NS; Richardson J; Moodley P; Moodley S; Babaria P; Ramtahal M; Heysell SK; Li X; Moll AP; Friedland G; Sturm AW; Gandhi NR
Emerg Infect Dis; 2011 Mar; 17(3):510-3. PubMed ID: 21392446
[TBL] [Abstract][Full Text] [Related]
60. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
